NCT05347199View on ClinicalTrials.gov

Effects of a Single Dose of Amisulpride on Functional Brain Changes

PHASE1CompletedINTERVENTIONAL

Enrollment

127

Participants

Timeline

Start Date

May 17, 2022

Primary Completion Date

September 18, 2023

Study Completion Date

September 25, 2023

Conditions

Major Depressive Disorder

Interventions

DRUG

Amisulpride Pill

Two single low doses amisulpride (100 mg); orally

DRUG

Placebo

two doses, orally

Trial Locations (1)

Unknown

Charité Research Organisation GmbH, Berlin

Sponsors

Collaborators (1)

Boehringer Ingelheim

All Listed Sponsors

collaborator

Charité Research Organisation GmbH

OTHER

collaborator

Boehringer Ingelheim

INDUSTRY

lead

Simone Grimm

OTHER

NCT05347199 - Effects of a Single Dose of Amisulpride on Functional Brain Changes | Biotech Hunter | Biotech Hunter